SLN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Silence Therapeutics PLC (SLN) is not a strong buy at the moment for a beginner investor with a long-term horizon. While the technical indicators show some bullish momentum, the lack of significant news, weak trading sentiment, and absence of recent financial data or strong catalysts make it a less compelling investment choice right now. The stock's price target has been lowered by analysts, and there are no signals from Intellectia Proprietary Trading Signals to suggest immediate action.
The stock shows bullish momentum with MACD above 0 and positively expanding, RSI in the neutral zone at 62.529, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 7.058 and 7.377, while support levels are at 6.027 and 5.708.
Bullish technical indicators, including MACD and moving averages.
Hedge funds and insiders are neutral, and there are no significant trading trends.
No financial data available for analysis.
Chardan analyst Keay Nakae lowered the price target to $27 from $35 while maintaining a Buy rating. This reflects a cautious outlook despite the Buy rating.
